Two-Shot strategy aims to shield newborns from hepatitis b
NCT ID NCT05705427
Summary
This study tested a simple way to prevent mothers from passing hepatitis B to their babies during birth. In the Democratic Republic of Congo, 317 pregnant women with hepatitis B received either a real medication or a placebo pill during late pregnancy. All their newborns got a hepatitis B vaccine shot within a day of birth. Researchers checked if this combined approach was safe, practical, and effective at stopping the virus from spreading to infants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Université Protestant au Congo
Kinshasa, Democratic Republic of the Congo
Conditions
Explore the condition pages connected to this study.